Gene · 3039
Papers3,980
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,980
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Thymus Functionality Needs More Than a Few TECs. | Front Immunol | 2022 | 35757725 | PubTator, text mining | PubMed |
| Single-cell atlas unveils cellular heterogeneity and novel markers in human neonatal and adult intervertebral discs. | iScience | 2022 | 35754733 | PubTator, text mining | PubMed |
| BIRC7 is Beneficial for Melanoma Progression and Hypoxic Response. | Clin Cosmet Investig Dermatol | 2022 | 35747741 | PubTator, text mining | PubMed |
| DIA-Based Proteomic Analysis of Plasma Protein Profiles in Patients with Severe Acute Pancreatitis. | Molecules | 2022 | 35745003 | PubTator, text mining | PubMed |
| JAK2 Unmutated Polycythaemia-Real-World Data of 10 Years from a Tertiary Reference Hospital. | J Clin Med | 2022 | 35743463 | PubTator, text mining | PubMed |
| Current and Novel Therapeutic Approaches for Treatment of Diabetic Macular Edema. | Cells | 2022 | 35741079 | PubTator, text mining | PubMed |
| Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis. | Cancers (Basel) | 2022 | 35740573 | PubTator, text mining | PubMed |
| Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs. | Antioxidants (Basel) | 2022 | 35739957 | PubTator, text mining | PubMed |
| Metabolic reprogramming under hypoxic storage preserves faster oxygen unloading from stored red blood cells. | Blood Adv | 2022 | 35736672 | PubTator, text mining | PubMed |
Molecular Determination of Vascular Endothelial Growth Factor, miRNA-423 Gene Abnormalities by Utilizing ARMS-PCR and Their Association with Fetal Hemoglobin Expression in the Patients with Sickle Cell Disease. | Curr Issues Mol Biol | 2022 | 35735616 | PubTator, text mining | PubMed |
| Potential biomarkers of spinal dural arteriovenous fistula: C4BPA and C1QA. | J Neuroinflammation | 2022 | 35733178 | PubTator, text mining | PubMed |
| Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet's disease. | Proc Natl Acad Sci U S A | 2022 | 35727985 | PubTator, text mining | PubMed |
| Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis. | Ren Fail | 2022 | 35713363 | PubTator, text mining | PubMed |
| The chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin. | Nat Commun | 2022 | 35710802 | PubTator, text mining | PubMed |
| Analysis of rare thalassemia genetic variants based on third-generation sequencing. | Sci Rep | 2022 | 35701592 | PubTator, text mining | PubMed |
| Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells. | J Am Heart Assoc | 2022 | 35699166 | PubTator, text mining | PubMed |
| METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours. | Ecancermedicalscience | 2022 | 35685961 | PubTator, text mining | PubMed |
| Screening a Panel of Topical Ophthalmic Medications against MMP-2 and MMP-9 to Investigate Their Potential in Keratoconus Management. | Molecules | 2022 | 35684529 | PubTator, text mining | PubMed |
| The Relevance of Physico-Chemical Properties and Protein Corona for Evaluation of Nanoparticles Immunotoxicity-In Vitro Correlation Analysis on THP-1 Macrophages. | Int J Mol Sci | 2022 | 35682872 | PubTator, text mining | PubMed |
| The impact of malaria-protective red blood cell polymorphisms on parasite biomass in children with severe Plasmodium falciparum malaria. | Nat Commun | 2022 | 35676275 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3039/papers?page=39